IKT

IKT Stock-Based Compensation

$19.96MTTM · USD

Period ending:

IKT FY Stock-Based CompUSD
IKT FY Stock-Based Comp2016-12-31: $310.09K2017-12-31: $300.66K2018-12-31: $642.23K2019-12-31: $1.44M2020-12-31: $573.70K2021-12-31: $1.53M2022-12-31: $458.15K2023-12-31: $500.15K2024-12-31: $8.14M2025-12-31: $15.31M$15.31M$0.00
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

IKT stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Inhibikase Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
15,309,924
8,140,617
500,148
458,147
1,531,876
573,695
1,436,608
642,231
300,659
310,088

Compare stock-based compensation

All IKT financial metrics · IKT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.